| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.096 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.083 | 0.1 |